Log In
Sign Up
Temozolamide
Indications
Astrocytoma, Glioblastoma, Brain metastases from solid tumours, and Melanoma
Dose/Application
Orally: Cycle length of 4 weeks: 150 mg/m2 (range 100-200 mg/m2) OD x 5/7 starting on day 1, OR OD x 5/7 starting on day 10 (total dose per cycle = 750 mg/m2, range 500-1000 mg/m2). Alternative 4 week cycle: 50-100 mg/m2 OD for 21-28 days starting on day 1. For parenteral 4 weeks cycle: 150 mg/m2 (range 100-200 mg/m2 IV OD x 5/7 (total dose per cycle = 750 mg/m2, range 500-1000 mg/m2). Concurrent radiation, cycle length of 3-7 weeks: 75 mg/m2 OD
Mode of action
Precautions
Contraindications
Side Effects
Pregnancy risk
Special information
Brands containing this Ingredient
Name Form. Strength Pack Price Insert Manufacturer Distributor
Drug Index 2.0 is here
Our new update features a more powerful search feature and easier login. Having any issues? Contact us today. Contact Us